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ABSTRACT 
A human fibrosarcoma cel line (HT1 080) consists of diploid (2N) and tetraploid (4N) cells 
at an equal rate. We first introduced a normal human chromosome 1， 2， 7， 1 or 12 into 
the 2N HT1080 cels. The microcell-hybrids with the introduction of chromosome 1 (2 
NMH-#1) showed suppression of tumorigenicity， alteration in cellular morphology and 
modu1ations of transformed properties in vitro， i.e.， cell-growth in medium containing 10 
% serum， growth in soft-agar and saturation density. The effect of chromosome 1 was 
on the suppression of tumorigenicity without changes in the in vitro growth behaviour of 
cels. 
In this study， transfers by microcell fusion of either chromosome 1， 2 or 1 into 4N HT1080 
cells were performed， and the ability to form tumor in nude mice and in vitro growth 
properties were compared with microcell hybrids(MH) from 2N HT1080 cels. We investigated 
wheather a putative tumor-supperessor gene on the introduced chromosome is involved in 
the gene dosage effect. 1) 4NMH-#1 were as non-tumorigenic as 2NMH-#1. 2) All 
2NMH-#11 were non-tumorigenic， whereas 4NMH-#11 were tumorigenic. 3) The introduction 
of chromosome 2 did not affect their tumorigenicity and in vitro transformed properties. 
Thus， a putative tumor suppressor gene on human chromosome 1 suppresses the neoplastic 
phenotype of 4N HT1080 cels. These findings suggest that the expression of tumorigenicity 
is regulated by a balance between positive and negative genes， and that the genes on 
chromosomes 1 and 1 control different neoplastic phenotypes. 
(Accepted on September 13， 1994) 
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Type Cu1ture Collection (A TCC)より取り寄せ
た.細胞は， 10%子牛血清を含むDMEM(Dul幽
becco's Modified Eagle's Medium)により培養し
た.染色体移入実験に用いた正常線維芽細胞由来







































































































































































































































































番 6番 9番， 11番染色体に抑制効果が認めら
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